4//SEC Filing
Lydon Nicholas 4
Accession 0001415889-23-010257
CIK 0001597264other
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 7:02 PM ET
Size
7.3 KB
Accession
0001415889-23-010257
Insider Transaction Report
Form 4
Lydon Nicholas
Director
Transactions
- Award
Common Stock
2023-06-21+2,600→ 55,784 total - Award
Stock Option (Right to Buy)
2023-06-21+5,300→ 5,300 totalExercise: $63.66Exp: 2033-06-21→ Common Stock (5,300 underlying)
Footnotes (2)
- [F1]The reported transaction involved the Reporting Person's receipt of a grant of restricted stock units. The restricted stock units vest with respect to 100% of the shares underlying the restricted stock units on the earlier of (i) June 21, 2024 and (ii) the next annual meeting of the Issuer's stockholders. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]This option vests with respect to 100% of the shares underlying the option on the earlier of (i) June 21, 2024 and (ii) the next annual meeting of the Issuer's stockholders.
Documents
Issuer
Blueprint Medicines Corp
CIK 0001597264
Entity typeother
Related Parties
1- filerCIK 0001639935
Filing Metadata
- Form type
- 4
- Filed
- Jun 22, 8:00 PM ET
- Accepted
- Jun 23, 7:02 PM ET
- Size
- 7.3 KB